Arkolith/Insider Trading/ADAP/Form 4

Behbahani Ali

DirectorAdaptimmune Therapeutics PLC (ADAP) · full profile →Form 4 · filed Aug 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$195K
Net Open-Market Flow
-$195K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)14.7M$0.01$147K0
Aug 15, 2025Sell(S)4.8M$0.01$48K14.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-110254) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML